FEB 02, 2016 01:24 PM PST

New DNA "Aptamer" Modifications for Disease Detection and Drug Delivery

WRITTEN BY: Kara Marker
Single-stranded molecules of DNA called “aptamers” have been studied since 1990 for their ability to bind and inhibit molecular targets, a useful behavior for disease detection and drug delivery (Nature). However, aptamers have not been approved for clinical use yet because of variable binding ability and quick digestion by enzymes. With two modifications, though, a team of researchers at the Institute of Bioengineering and Nanotechnology (IBN) at the Agency for Science, Technology and Research (A*STAR), could soon be on the way to developing the first approved aptamer technology.
 
Just like the antibodies produced by the immune system that target foreign pathogens, aptamers have the potential to become a specialized army for infectious diseases. However, just like medicine, aptamers need time in the bloodstream to find and bind to their target. If they are quickly and easily digested by enzymes waiting in the blood stream, the aptamers will not have time to act, making their effectiveness irrelevant.
 

IBN Principal Research Scientist and Team Leader Dr. Ichiro Hirao and a team of researchers from A*STAR equipped their aptamers with a sequence of DNA called a “mini hairpin DNA” to prevent enzyme digestion, allowing the aptamers time to find and inhibit their targets. With the mini hairpin DNA, aptamers can survive for days rather than hours, as the DNA sequence acts as a “protective shield.”
 
Hirao’s team also overcame the problem of aptamer binding capabilities by adding an “unnatural base” that improved binding by 100 percent. Unnatural bases were developed to supplement the natural bases – A, T, G, and C (Nature). In this case, the extra component of the single-strand of DNA greatly enhanced its binding capabilities.
 
We hope to use our DNA aptamers as the platform technology for diagnostics and new drug development," said IBN Executive Director Professor Jackie Y. Ying. Scientists from the IBN plan to soon begin testing the aptamers for specific diseases. Their current study is published in the journal Scientific Reports.
 

Source: A*STAR
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 12, 2018
Cell & Molecular Biology
NOV 12, 2018
A New Look at Messenger RNA
Researchers have discovered that longstanding textbook knowledge about an important molecule called mRNA is probably incorrect....
DEC 17, 2018
Genetics & Genomics
DEC 17, 2018
Autism Risk Increased by Mutations in Non-Coding Regions
People have been desperate to learn more about the potential causes of autism, and researchers have been making some progress in recent years....
DEC 26, 2018
Immunology
DEC 26, 2018
When the Immune System Makes a Mistake: Autoimmunity
A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's healthy cells....
DEC 29, 2018
Microbiology
DEC 29, 2018
A Microbe's Membrane Protects It From Extreme Environments
There are microscopic organisms called archaea living in some of Earth's most intense environments....
JAN 03, 2019
Genetics & Genomics
JAN 03, 2019
Why the Tuberculosis Bacterium Sickens Some but not Others
Incredibly, around 20% of the global population is infected with the microbe that causes TB, but only about 10% show any signs of illness....
JAN 05, 2019
Cell & Molecular Biology
JAN 05, 2019
The Body's Largest Cellular Receptor is Identified
The structure of a huge receptor in the body, which binds to vitamin B12, has now been elucidated....
Loading Comments...